
Rx Report
How Rx Report Works
From a single cheek swab to clinically actionable medication guidance, built on the broadest second-generation pharmacogenomic panel and a proprietary multi-gene algorithm.
The Rx Report™ takes the underlying science of pharmacogenomics and translates it into specific, prescriber-ready recommendations. It does this by analyzing the maximum number of pharmacokinetic and pharmacodynamic genes recognized by leading scientific platforms (PharmGKB, CPIC, the FDA) and weighting them by levels of evidence.
That breadth of inputs is the foundation of meaningful guidance, especially in mental-health prescribing where small dosing differences can decide whether a treatment helps or harms.
From Sample to Recommendation
- Go to PPI’s website1

- Purchase Rx Report: Psychiatry & Pain2

Order the Rx Report™: Psychiatry & Pain test
- Case‑pharmacist3
Sandra Hanna
Cindy Hsieh
Sara TemkitPatient is assigned to a case-pharmacist who reaches out for their clinical and medication history
- Sign consent form4

Patient receives a separate email to sign the consent form
- Receive sample kit5

PPI sends a DNA swab sample collection kit with instructions
- Home sample collection6

Patients collect their sample and mail it back with the pre-paid envelope enclosed in the kit
- Sample processing7

PPI’s lab processes the sample and the results are uploaded to PPI software
- Receive / view test report8

Case-pharmacist interprets and sends the personalized report to patient and physician · www.p3report.com
- Post-test consultation9

Patients may schedule a post-test consultation with their case-pharmacist (optional)
Built for Predictive Power
The Rx Report™ Algorithm
A pharmacogenomic test must analyze a maximum number of pharmacokinetic and pharmacodynamic genes recognized by leading scientific platforms (PharmGKB, CPIC, the FDA) and weight them by levels of evidence. That is the foundation of meaningful guidance, especially in mental-health prescribing.
104
SNPs analyzed
59
Genes covered
The Rx Report™ tests offered by Personalized Prescribing Inc. use a multiple-genes approach to provide medication recommendations that have shown significant improvement in clinical outcomes for patients with depression and anxiety. Recommendations are based on algorithms across 104 SNPs from 59 genes, spanning multiple metabolic and neurotransmitter pathways, programmed in proprietary software, contributing to greater predictive power for patient outcomes.
Want the underlying science?
The Rx Report sits on top of decades of pharmacogenomics research. If you’d like the “why” behind how genes shape medication response, start with the general walkthrough.
What Is Pharmacogenetics?Ready to See Your Own Results?
Order an Rx Report and turn your unique genetic profile into personalized, evidence-based prescribing guidance.
